Aymen Akil

Ayman Akil, PhD is a modeling and simulation expert specializing in Model-Informed Drug Development (MIDD) and AI-driven pharmacometrics. As Director of Quantitative Science Services at Certara, he leads U.S.-based pharmacometrics consulting, applying population PK, exposure-response, and PK/PD modeling to optimize drug development. With a PhD in Pharmaceutical Sciences (University of Pittsburgh) and a fellowship in Disease & Therapeutic Response Modeling (Indiana University), Dr. Akil has held roles at Synteract, Mercer University, and Indiana University School of Medicine. His research spans Pharmacometrics and AI-driven drug modeling, leveraging tools like Phoenix WinNonlin, NONMEM, and R.